Medicine and Dentistry
Neoplasm
100%
Hypoxia
65%
Radiation Therapy
64%
Biological Marker
27%
Xenograft
23%
In Vitro
23%
Tumor Hypoxia
20%
Tumor Xenograft
20%
Magnetic Resonance Imaging
19%
Cancer Cell
17%
Metastatic Carcinoma
17%
Thyroid Carcinoma
16%
Tumor Cell
16%
Small Cell Lung Cancer
15%
Hypoxia Inducible Factor 1
12%
Phosphotransferase
12%
Malignant Neoplasm
12%
Radiation Response
11%
Prostate Cancer
11%
Cediranib
11%
Vasculotropin
10%
Tumor Progression
10%
Radiosensitivity
9%
Programmed Cell Death
9%
Breast Cancer
9%
Upregulation
9%
Colorectal Cancer
8%
Cancer Model
8%
Dosimetry
8%
Interferon
8%
Phosphoinositide 3-Kinase
8%
Carcinogenesis
8%
Carbonate Dehydratase IX
7%
Adenosine Diphosphate
7%
Immune Checkpoint Inhibitor
7%
Polymerase
7%
Phosphatidylinositide
7%
Lung Tumor
7%
Antiangiogenic
7%
Nitric Oxide Synthase
7%
Base
7%
Banoxantrone
7%
Bladder Cancer
7%
Treatment Response
7%
Mitogen-Activated Protein Kinase
7%
Glioblastoma
7%
Solid Malignant Neoplasm
6%
Cytotoxicity
6%
Selumetinib
6%
Tumor Microenvironment
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
89%
Hypoxia
55%
Malignant Neoplasm
18%
Biological Marker
13%
Cytotoxicity
11%
Fluorine 18
11%
Mouse
9%
Hypoxia Inducible Factor 1
9%
Tumor Growth
9%
Anticarcinogen
8%
Disease
8%
Carbonate Dehydratase
8%
Breast Cancer
8%
Tumor Microenvironment
8%
Carbonate Dehydratase IX
7%
Cediranib
7%
Thyroid Carcinoma
7%
Tirapazamine
7%
Small Cell Lung Cancer
7%
Monocarboxylate Transporter 1
7%
Antiangiogenic
7%
Base
7%
1 (2 Bromoethylamino) 3 (2 Nitro 1 Imidazolyl) 2 Propanol
7%
Oxidoreductase
7%
Selumetinib
6%
Primary Tumor
6%
Reduced Nicotinamide Adenine Dinucleotide (Phosphate) Dehydrogenase (Quinone)
6%
Solid Malignant Neoplasm
6%
Chemotherapy
6%
Prodrug
6%
Tumor Model
5%
Monocarboxylate Transporter
5%
Cytotoxin
5%
Cisplatin
5%
Vasculotropin
5%
Gelatin
5%
Drug Resistance
5%
Biochemistry, Genetics and Molecular Biology
Hypoxia Inducible Factor 1
19%
Cancer Cell
10%
Gene Expression
8%
Carcinogenesis
8%
Metabolite
7%
Tumor Progression
7%
Vascular Endothelial Growth Factor
7%
Promoter Region
6%
Enhancer Region
5%
Ataxia Telangiectasia Mutated
5%
Cytotoxicity
5%